TY  - JOUR

T1  - First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study

JO  - Cancer Research Communications

UR  - http://dx.doi.org/10.1158/2767-9764.crc-23-0459

PY  - 2024/04/26

AU  - Wheatley DA

AU  - Berardi R

AU  - Climent Duran MA

AU  - Tomiak A

AU  - Greystoke AP

AU  - Joshua AM

AU  - Arkenau H-T

AU  - Géczi L

AU  - Garcia-Corbacho J

AU  - Paz-Ares LG

AU  - Hussain SA et al

ED  - 

DO  - DOI: 10.1158/2767-9764.crc-23-0459

PB  - American Association for Cancer Research (AACR)

Y2  - 2024/12/22

ER  -